27th Annual EuroMeeting

Medical affairs organisations have emerged over the past half century in response to federal regulations around the separation of medical and commercial activities within drug companies. Many companies also chose to focus R&D resources on developing new products and moved post-launch activities, such as finding new indications for existing drugs, into the medical affairs function. Continued pressure from regulatory agencies and public sentiment have pushed more and more activities into Medical affairs organisations. Today, these organisations commonly involve the following medical activities: Medical education, medical field teams, post-launch clinical trials, medical-information services, medical communications, medical strategic activities and health economics and outcome research activities. The vision from medical departments of three global pharmaceutical companies will be addressed and balanced with the vision of the Standing Committee of the European Doctors (CPME).